Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.94 - $4.77 $31,331 - $50,833
-10,657 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$4.07 - $5.3 $43,373 - $56,482
10,657 New
10,657 $48,000
Q3 2021

Nov 15, 2021

SELL
$4.7 - $7.24 $91,913 - $141,585
-19,556 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$6.81 - $10.93 $133,176 - $213,747
19,556 New
19,556 $133,000
Q2 2018

Aug 14, 2018

SELL
$10.2 - $13.9 $126,704 - $172,665
-12,422 Closed
0 $0
Q1 2018

Jun 14, 2018

SELL
$12.65 - $18.85 $94,293 - $140,507
-7,454 Reduced 37.5%
12,422 $162,000
Q1 2018

May 14, 2018

BUY
$12.65 - $18.85 $251,431 - $374,662
19,876 New
19,876 $259,000

Others Institutions Holding PRTK

About Paratek Pharmaceuticals, Inc.


  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.